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Abstract: In previous studies we found expression of the protein colligin 2 (heat shock protein 47 (HSP47), SERPINH1) in glioma 
neovasculature while not in normal brain tissue. Generally, the regulation of heat shock gene expression in eukaryotes is mediated 
by heat shock factors (HSF). In mammals, three heat shock transcription factors, HSF-1, -2, and -4, have been isolated. Here we 
investigated the relation between the expression of colligin 2 and these heat shock factors at the mRNA level using real-time reverse 
transcriptase PCR (qRT-PCR) in different grades of astrocytic tumorigenesis, viz., low-grade glioma and glioblastoma. Endometrium 
samples, representing physiological angiogenesis, were included as controls. Since colligin 2 is a chaperon for collagens, the gene 
expression of collagen I (COL1A1) was also investigated. The blood vessel density of the samples was monitored by expression of the 
endothelial marker CD31 (PECAM1). Because NG2-immunopositive pericytic cells are involved in glioma neovascularization, the 
expression of NG2 (CSPG4) was also measured.
We demonstrate overexpression of HSF2 in both stages of glial tumorigenesis (reaching significance only in low-grade glioma) and 
also minor elevated levels of HSF1 as compared to normal brain. There were no differences in expression of HSF4 between low-grade 
glioma and normal brain while HSF4 was downregulated in glioblastoma. In the endometrium samples, none of the HSFs were upregu-
lated. In the low-grade gliomas SERPINH appeared to be slightly overexpressed with a parallel 4-fold upregulation of COL1A1, while in 
glioblastoma there was over 5-fold overexpression of SERPINH1 and more than 150-fold overexpression of COL1A1. In both the low-
grade gliomas and the glioblastomas overexpression of CSPG4 was found and overexpression of PECAM1 was only found in the latter. 
Our data suggest that the upregulated expression of colligin 2 in glioma is accompanied by upregulation of COL1A1, CSPG4, HSF2 
and to a lesser extent, HSF1. Further studies will unravel the association of these factors with colligin 2 expression, possibly leading to 
keys for therapeutic intervention. 
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A  wide  range  of  physiological  and  pathological 
stresses trigger the heat shock gene transcription. Cells 
respond to elevated temperatures and to chemical and 
physiological stresses by an increase in the synthesis 
of heat shock proteins. HSP are a highly conserved 
family of proteins which function as molecular chap-
erones or proteases.1,2 Molecular chaperones form a 
class of proteins that control the proper folding of 
nascent polypeptides into the correct 3D structure. 
During stress responses the role of HSPs is critical in 
preventing the appearance of intermediates that lead 
to  misfolding  or  otherwise  damaging  molecules.3 
HSPs  assist  in  the  recovery  from  stress  either  by 
repairing  damaged  proteins  (protein  refolding),  or 
protein degrading, thus restoring protein homeostasis 
and promoting cell survival. The regulation of heat 
shock proteins is mediated by heat shock transcrip-
tion factors (HSF). Under normal conditions, HSFs 
reside in the cytoplasm, but are activated upon stress 
and relocalize to the cell nuclei.4 Activated HSFs form 
a trimmer with high-affinity binding to DNA; it binds 
to heat shock elements (HSE) in the promoters of 
the heat shock genes.4 The activation results in the 
expression  of  heat  shock  proteins  (HSPs).  In  ver-
tebrates and plants, there are at least four members 
of the HSF gene family (HSF1–4),1 while in human 
cells,  three  HSFs  (HSF-1,  -2,  and  -4)  have  been 
characterized.2,5 The expression of HSF1 and HSF2 
is ubiquitous. However, the factors that induce their 
activation  differ. While  HSF1  is  activated  by  heat 
shock and other forms of stress, HSF2 activity has 
been  associated  with  development  and  differentia-
tion. The expression of HSF4 appears to be tissue-
specific and is restricted to heart, skeletal muscle or 
brain.5 The simultaneous expression of the different 
HSFs in particular tissues would enable differential 
responses to various forms of stress. In the context of 
tumors, HSPs may be tumor-specific and therefore, 
they may well become therapeutic targets.6–8
In  previous  studies,  we  found  specific  overex-
pression  of  colligin  2  in  glioma  neovasculature  as 
  compared  to  the  normal  vasculature  of  the  brain.9,10 
Here  we  investigate  whether  there  is  a  correlation 
between the expression of colligin 2 and any of the 
HSF  genes  (HSF1,  HSF2  and  HSF4)  at  the  mRNA 
level in   low- and high-grade glioma. We isolated RNA 
from human frozen samples by using RNeasy Micro kit 
(Qiagen BV, Venlo, The Netherlands). We measured the 
relative transcription levels of colligin 2 (SERPINH1), 
HSF1, 2 and 4 by real time RT-PCR in four glioblastoma 
(GBM)  samples,  four  samples  of  low-grade  glioma 
(LGG), four samples of proliferating endometrium and 
four samples of normal brain tissue. Prior to isolation 
all tissues were assessed by a qualified pathologist to 
ensure the origin and quality of the tissues. The blood 
vessel density of the samples was monitored by expres-
sion  of  the  endothelial  marker  CD31  (PECAM1).11 
Because  NG2-immunopositive  pericytic  cells  are 
involved in glioma neovascularization, the expression 
of NG2 (CSPG4) was also measured. The expression 
sites of the HSFs were visualized by confocal micros-
copy. NormFinder with the Datan Framework GenEx 
Pro package version 4.3.2 was used to calculate the most 
stable mRNA set for our four tissue groups.12 Therefore, 
a set of four reference genes were used for data normal-
ization (GUSB, HMBS, HPRT1 and NOXA1) (see also 
our supplementary file). For statistical testing the mean 
values were used. Comparisons between groups were 
made by using the Kruskal Wallis test.
qRT-PCR revealed a significant 5.6-fold increase 
in mRNA levels for colligin 2 in glioblastoma and 
mildly elevated levels in low-grade glioma (Fig. 1). 
In parallel, significant increases in mRNA levels of 
collagen type I was found in the gliomas. Of the heat 
shock  factors,  HSF2  was  overexpressed  in  glioma 
which  reached  significance  in  low-grade  glioma. 
There was only minor overexpression of HSF1 while 
HSF4 was underexpressed in GBM (Fig. 1). Different 
types  of  blood  vessels  in  glioblastoma  showed  a 
coexpression of both HSF1 and colligin 2. Endothe-
lial cells of small blood vessels that expressed HSF1 
were also immunopositive for colligin 2 (Fig. 2A). 
Additionally, some cells that compose the vessel wall 
of hypertrophied vessels co-expressed colligin 2 and 
HSF1  whiule  others  showed  colligin  2  expression 
only (Fig. 2B). In GBM both PECAM1 (1.8-fold) and 
CSPG4  (2.3-fold)  were  overexpressed  while  only 
CSPG4  was  overexpressed  (3.4-fold)  in  LGG. We 
also observed 2.2-fold upregulation of the expression 
of colligin 2 mRNA in endometrium samples as com-
pared to normal controls (not significant; P = 0.0833) 
with significant 55-fold upregulation of the expression 
of collagen I mRNA (P = 0.0209). Remarkably, none 
of the HSFs was upregulated in endometrium as com-
pared to normal brain controls (HSF1: P = 0.1489; 
HSF2: P = 0.2482; HSF4: P = 0.2482).heat shock factors in glioblastoma angiogenesis
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Figure  1.  mRNA  expression  of  colligin  2,  hSF1,  2  and  3,  collagen  1,  CD31  and  NG2  in  low-  and  high-grade  glioma  and  normal  control  brain. 
Data in this figure are the average ± SD of one representative experiment with 4 tissues in each group. expression data are presented relative to the aver-
age mRNA expression levels measured in total RNA isolated from normal brain tissues (n = 4). Prior to isolation, all tissues were assessed by a qualified 
pathologist to ensure the origin and quality of the tissues. Total RNA was isolated with the RNeasy Micro kit (Qiagen BV, Venlo, The Netherlands). cDNA 
was prepared by use of the RevertAid h Minus First Strand cDNA synthesis kit (Fermentas, St Leon-Rot, Germany). The resulting cDNA preparations 
were analyzed by real-time pCR with TaqMan gene expression assays and TaqMan Universal pCR Master Mix (Applied Biosystems, Nieuwerkerk a/d 
IJssel, The Netherlands). pCRs were performed in a 20 µL reaction volume in an Applied BioSystems 7900hT Fast Real-Time pCR system. Negative 
controls included minus RT and h2o-only samples, which showed to be negative in all cases. The most stable mRNA set for our 4 tissue groups were 
calculated with NormFinder19 with the Datan Framework Genex pro package version 4.3.2 and was shown to be a combination of GUSB, HMBS, HPRT1 
and NOXA1. expression of GUSB, HMBS, HPRT1 and NOXA1 was therefore used as a reference to control sample loading and RNA quality, as described 
  previously.20
Differences in mRNA concentrations were determined by the non parametric Kruskal-Wallis test with P , 0.05 being considered statistically significant. 
All statistical tests were two-sided.
Abbreviations: LGG, low grade glioma; GBM, glioblastoma; SERPINH1, mRNA coding for colligin 2; COL1A1, mRNA coding for collagen 1; HSF, mRNA coding for heat 
shock factor; PECAM1, mRNA coding for CD31; CSPG4, mRNA coding for NG2; RT-PCR, reverse transcriptase–polymerase chain reaction; cDNA, complementary DNA.
Several studies showed the transcription of HSP 
genes requires the activation and translocation to the 
nucleus of heat shock factors (HSF’s).13 It has been 
shown that HSF1 induces the mRNA expression of 
colligin 2 in rats14 and in young zebrafish.15 This is the 
first report on the parallel upregulation of colligin 2 
and heat shock factors in human glioma. Heat shock 
responses appear to be implicated in a broad range 
of  pathological  conditions  including  heat  shock, 
oxidative  stress,  ischemia  and  reperfusion,  inflam-
mation, tissue damage, exposure to heavy metals and 
infection.1 In addition, tumor neovascularization is 
associated with the heat shock response. Mammals 
have three different HSFs which are considered to 
be  functionally  distinct:  HSF1  is  essential  for  the 
heat shock response and is also required for devel-
opmental  processes;  HSF2  and  HSF4  are  impor-
tant for differentiation and development.16 Although 
deletion of HSF1 in mammalian cells still allows a 
basal expression of HSPs, it leads to the abrogation of 
induction of the response to a variety of stresses.17,18 
The genes encoding HSF1 and HSF2 are constitu-
tively expressed in most cell lines and tissues under 
normal growth conditions and both factors are kept 
in a latent, non-DNA-binding state, indicating that 
the DNA-binding activity of both HSF1 and HSF2 is 
negatively regulated.19 Despite differences in expres-
sion, HSF1 and HSF2 both act as positive activators of 
transcription for all their functions. In contrast, HSF4 
lacks activity of a transcriptional activator.20 HSF4 is 
highly expressed in the lens and in brain. It may well 
be a HSE binding trimmer because it lacks an inhibi-
tory  domain  of  trimerization.  HSF4  constitutively 
binds to DNA and regulates the expression of HSP 
in the absence of stress.21 HSF4 contains two alter-
native splice variants: HSF4a and HSF4b.22 HSF4a Mustafa et al
106  Gene Regulation and Systems Biology 2010:4
isoform acts as a repressor of HSF122 by competi-
tively binding to the heat shock element (HSE). This 
is the first observation of downregulation of HSF4 in 
glioblastoma and is suggestive of a role of HSF4 in 
the regulation of the expression of HSPs including 
colligin 2. High-resolution chromatin immunoprecip-
itation on microarray (ChIP-chip) screens have suc-
cessfully been used for identifying direct target genes 
for many transcription factors.23 This approach has 
also been used for searching target genes for HSF216 
and may be used for further unravelling the relation 
between HSF2, HSF1, HSF4 and colligin 2. In the 
proliferating endometrium samples we found overex-
pression of colligin 2 and collagen type I. In contrast 
to the glioma samples, no associated upregulation of 
any of the three HSFs was observed in these samples 
(data not shown; please see the supplementary file). 
This may well be an important difference between 
physiological  and  neoplastic  angiogenesis.  Obvi-
ously, if there is a causal relation between the upregu-
lated HSFs found and the expression of colligin 2, the 
HSFs may become important for the design of anti-
angiogenic therapy.
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